These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mild cognitive impairment and its management in older people. Eshkoor SA; Hamid TA; Mun CY; Ng CK Clin Interv Aging; 2015; 10():687-93. PubMed ID: 25914527 [TBL] [Abstract][Full Text] [Related]
3. Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials. Ströhle A; Schmidt DK; Schultz F; Fricke N; Staden T; Hellweg R; Priller J; Rapp MA; Rieckmann N Am J Geriatr Psychiatry; 2015 Dec; 23(12):1234-1249. PubMed ID: 26601726 [TBL] [Abstract][Full Text] [Related]
4. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia. Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799 [TBL] [Abstract][Full Text] [Related]
5. The status of ongoing trials for mild cognitive impairment. Sramek JJ; Veroff AE; Cutler NR Expert Opin Investig Drugs; 2001 Apr; 10(4):741-52. PubMed ID: 11281823 [TBL] [Abstract][Full Text] [Related]
6. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia]. Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ; Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080 [TBL] [Abstract][Full Text] [Related]
7. The optimal treatment for improving cognitive function in elder people with mild cognitive impairment incorporating Bayesian network meta-analysis and systematic review. Liang JH; Shen WT; Li JY; Qu XY; Li J; Jia RX; Wang YQ; Wang S; Wu RK; Zhang HB; Hang L; Xu Y; Lin L Ageing Res Rev; 2019 May; 51():85-96. PubMed ID: 30682429 [TBL] [Abstract][Full Text] [Related]
8. The diagnosis and management of mild cognitive impairment: a clinical review. Langa KM; Levine DA JAMA; 2014 Dec; 312(23):2551-61. PubMed ID: 25514304 [TBL] [Abstract][Full Text] [Related]
9. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia. Morris JC Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163 [TBL] [Abstract][Full Text] [Related]
10. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment. Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809 [TBL] [Abstract][Full Text] [Related]
11. Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia. Han JY; Besser LM; Xiong C; Kukull WA; Morris JC Alzheimer Dis Assoc Disord; 2019; 33(2):87-94. PubMed ID: 30633043 [TBL] [Abstract][Full Text] [Related]
12. Treatment for mild cognitive impairment: systematic review. Cooper C; Li R; Lyketsos C; Livingston G Br J Psychiatry; 2013 Sep; 203(3):255-64. PubMed ID: 24085737 [TBL] [Abstract][Full Text] [Related]
13. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study. Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease. Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215 [TBL] [Abstract][Full Text] [Related]
16. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Grundman M; Petersen RC; Ferris SH; Thomas RG; Aisen PS; Bennett DA; Foster NL; Jack CR; Galasko DR; Doody R; Kaye J; Sano M; Mohs R; Gauthier S; Kim HT; Jin S; Schultz AN; Schafer K; Mulnard R; van Dyck CH; Mintzer J; Zamrini EY; Cahn-Weiner D; Thal LJ; Arch Neurol; 2004 Jan; 61(1):59-66. PubMed ID: 14732621 [TBL] [Abstract][Full Text] [Related]
17. Prognosis of mild cognitive impairment in general practice: results of the German AgeCoDe study. Kaduszkiewicz H; Eisele M; Wiese B; Prokein J; Luppa M; Luck T; Jessen F; Bickel H; Mösch E; Pentzek M; Fuchs A; Eifflaender-Gorfer S; Weyerer S; König HH; Brettschneider C; van den Bussche H; Maier W; Scherer M; Riedel-Heller SG; Ann Fam Med; 2014; 12(2):158-65. PubMed ID: 24615312 [TBL] [Abstract][Full Text] [Related]
18. A profile of The Clinical Course of Cognition and Comorbidity in Mild Cognitive Impairment and Dementia Study (The 4C study): two complementary longitudinal, clinical cohorts in the Netherlands. Liao W; Hamel RE; Olde Rikkert MG; Oosterveld SM; Aalten P; Verhey FR; Scheltens P; Sistermans N; Pijnenburg YA; van der Flier WM; Ramakers IH; Melis RJ BMC Neurol; 2016 Nov; 16(1):242. PubMed ID: 27884130 [TBL] [Abstract][Full Text] [Related]